메뉴 건너뛰기




Volumn 11, Issue 2, 2010, Pages 195-203

A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden

Author keywords

Cost effectiveness; Pharmaceuticals; Reimbursement; Value based pricing

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; RIMONABANT;

EID: 77954888008     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-009-0166-1     Document Type: Review
Times cited : (39)

References (34)
  • 2
    • 77954887019 scopus 로고    scopus 로고
    • The pharmaceutical price regulation scheme. An OFT market study
    • Office of Fair Trading, February
    • Office of Fair Trading.: The pharmaceutical price regulation scheme. An OFT market study. Office of Fair Trading, February (2007)
    • (2007) Office of Fair Trading
  • 4
    • 0242571874 scopus 로고    scopus 로고
    • Heälso-och sjukvården behöver kunskap om hur befolkningen värderar hälsan
    • Persson, U., Hjelmgren, J.: Heälso-och sjukvården behöver kunskap om hur befolkningen värderar hälsan. Läkartidningen. 100(Nr 43), 3436-3437 (2003)
    • (2003) Läkartidningen. , vol.100 , Issue.43 , pp. 3436-3437
    • Persson, U.1    Hjelmgren, J.2
  • 6
    • 77954888365 scopus 로고    scopus 로고
    • Kostnadsutveckling i svensk sjukvård relaterad till övervikt och fetma-några scenarier. Vårdens resursbehov och utmaningar på längre sikt
    • Persson, U., Svensson, M., Ödegaard, K.: Kostnadsutveckling i svensk sjukvård relaterad till övervikt och fetma-några scenarier. Vårdens resursbehov och utmaningar på längre sikt. Landstingsförbundet, Stockholm (2004)
    • (2004) Landstingsförbundet, Stockholm
    • Persson, U.1    Svensson, M.2    Ödegaard, K.3
  • 7
    • 27744491391 scopus 로고    scopus 로고
    • Obesity, survival and hospital costs-findings from a screening project in Sweden
    • Borg, S., Persson, U., Ödegaard, K., Berglund, G., Nilsson, J.-Å ., Nilsson, P.: Obesity, survival and hospital costs-findings from a screening project in Sweden. Value Health. 8(5), 562-571 (2005)
    • (2005) Value Health. , vol.8 , Issue.5 , pp. 562-571
    • Borg, S.1    Persson, U.2    Ödegaard, K.3    Berglund, G.4    Nilsson, J.-Å.5    Nilsson, P.6
  • 8
    • 39649116638 scopus 로고    scopus 로고
    • The Swedish cost burden of overweight and obesity-evaluated with the PAR approach and a statistical modelling approach
    • Ödegaard, K., Borg, S., Persson, U., Svensson, M. The Swedish cost burden of overweight and obesity-evaluated with the PAR approach and a statistical modelling approach. Int. J. Pediatr. Obes. 3, 51-57 (2008)
    • (2008) Int. J. Pediatr. Obes. , Issue.3 , pp. 51-57
    • Ödegaard, K.1    Borg, S.2    Persson, U.3    Svensson, M.4
  • 9
    • 14944339043 scopus 로고    scopus 로고
    • Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data
    • Bagust, A., Sophi, B.: Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ. 14, 217-230 (2005)
    • (2005) Health Econ. , vol.14 , pp. 217-230
    • Bagust, A.1    Sophi, B.2
  • 10
    • 27744569367 scopus 로고    scopus 로고
    • The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): Descriptive analysis from the first 20, 000 subjects
    • Currie, C.J., McEwan, P., Burgess, J., Peters, J.R., Patel, T.C., Dixon, S.: The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20, 000 subjects. Value Health. 8(5), 581-590 (2006)
    • (2006) Value Health. , vol.8 , Issue.5 , pp. 581-590
    • Currie, C.J.1    McEwan, P.2    Burgess, J.3    Peters, J.R.4    Patel, T.C.5    Dixon, S.6
  • 11
    • 37249083878 scopus 로고    scopus 로고
    • Long term pharmacotherapy for obesity and overweight: Updated metaanalysis
    • Rucker, D., Padwal, R., Li, S.K., Curioni, C., Lau, D.C.: Long term pharmacotherapy for obesity and overweight: updated metaanalysis. Br. Med. J. 335, 1194-1199 (2007)
    • (2007) Br. Med. J. , vol.335 , pp. 1194-1199
    • Rucker, D.1    Padwal, R.2    Li, S.K.3    Curioni, C.4    Lau, D.C.5
  • 12
    • 17144382751 scopus 로고    scopus 로고
    • Effects of the cannobinoid-1 receptor blocker Acomplia on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIOEurope study
    • Van Gaal, Luc F., et al.: Effects of the cannobinoid-1 receptor blocker Acomplia on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIOEurope study. Lancet. 365(9468), 1389-1397 (2005)
    • (2005) Lancet. , vol.365 , Issue.9468 , pp. 1389-1397
    • Van Gaal Luc, F.1
  • 13
    • 27844463517 scopus 로고    scopus 로고
    • Effects of Acomplia on metabolic risk factors in overweight patients with dyslipidemia
    • Despres, J.P., et al.: Effects of Acomplia on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353(20), 2121-2134 (2005)
    • (2005) N. Engl. J. Med. , vol.353 , Issue.20 , pp. 2121-2134
    • Despres, J.P.1
  • 14
    • 32644441249 scopus 로고    scopus 로고
    • Effect of Acomplia, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: A randomized controlled trial
    • Pi-Sunyer, F.X., et al.: Effect of Acomplia, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA. 295(7), 761-775 (2006)
    • (2006) JAMA. , vol.295 , Issue.7 , pp. 761-775
    • Pi-Sunyer, F.X.1
  • 16
    • 3042622492 scopus 로고    scopus 로고
    • Systematic review of long-term effects and economic consequences of treatment for obesity and implication for health improvement
    • Avenell, A., et al.: Systematic review of long-term effects and economic consequences of treatment for obesity and implication for health improvement. Health technology assessment, vol 8, No 21 (2004)
    • (2004) Health Technology Assessment , vol.8 , Issue.21
    • Avenell, A.1
  • 17
    • 77954886628 scopus 로고    scopus 로고
    • Consumption and production by age in Sweden: Basic facts and health economic implication
    • Dissertation for the degree of Doctor of Philosophy at the Stockholm School of Economics. EFI, Stockholm, Sweden
    • Ekman, Mattias. Consumption and production by age in Sweden: Basic facts and health economic implication. In Ekman M. Studies in health economics: Modelling and data analysis of costs and survival. Dissertation for the degree of Doctor of Philosophy at the Stockholm School of Economics. EFI, Stockholm, Sweden (2002)
    • (2002) Ekman M. Studies in Health Economics: Modelling and data Analysis of Costs and Survival
    • Mattias, E.1
  • 18
    • 77954887776 scopus 로고    scopus 로고
    • Läkemedelsförmånsnämnden (LFN), Beslut (Decision) Stockholm 1023/2006
    • Läkemedelsförmånsnämnden (LFN) Beslut (Decision) Stockholm 1023/2006
  • 19
    • 77954888045 scopus 로고    scopus 로고
    • Läkemedelsförmånsnämnden (LFN), Beslut (Decision) Stockholm 59/2008
    • Läkemedelsförmånsnämnden (LFN) Beslut (Decision) Stockholm 59/2008
  • 20
    • 77954886915 scopus 로고    scopus 로고
    • Läkemedelsförmånsnämnden (LFN), Beslut (Decision) Stockholm 34/2002
    • Läkemedelsförmånsnämnden (LFN) Beslut (Decision) Stockholm 34/2002
  • 21
    • 33747870163 scopus 로고    scopus 로고
    • Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old
    • Adams Kenneth, F., et al.: Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med. 355(8), 763-778 (2006)
    • (2006) N. Engl. J. Med. , vol.355 , Issue.8 , pp. 763-778
    • Adams Kenneth, F.1
  • 23
    • 11144298966 scopus 로고    scopus 로고
    • A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: The United Kingdom prospective diabetes study (UKPDS) Outcomes model (UKPDS no. 68)
    • Clarke, P., Gray, A., Briggs, A., Farmer, A., Fenn, P., Stevens, R., Mathews, D., Stratton, I., Holman, R.: A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 47, 1747-1759 (2004)
    • (2004) Diabetologia , vol.47 , pp. 1747-1759
    • Clarke, P.1    Gray, A.2    Briggs, A.3    Farmer, A.4    Fenn, P.5    Stevens, R.6    Mathews, D.7    Stratton, I.8    Holman, R.9
  • 25
    • 77954888249 scopus 로고    scopus 로고
    • FASS, assumed to remain unchanged for 2006
    • FASS. http://www.fass.se/, assumed to remain unchanged for 2006 (2005)
    • (2005)
  • 26
    • 0038579421 scopus 로고    scopus 로고
    • Estimation of ten year risk of fatal cardiovascular disease in Europe: The SCORE project
    • for the SCORE project group
    • Conroy, R.M., for the SCORE project group, et al.: Estimation of ten year risk of fatal cardiovascular disease in Europe: the SCORE project. EUR. Heart J. 24, 987-1003 (2003)
    • (2003) EUR. Heart J. , vol.24 , pp. 987-1003
    • Conroy, R.M.1
  • 28
    • 0033823270 scopus 로고    scopus 로고
    • Coronary hearth disease incidence in northern and southern European population: A reanalysis of seven countries study for a European coronary risk chart
    • Menotti, A., Lanti, M., Puddu, P.E., et al.: Coronary hearth disease incidence in northern and southern European population: a reanalysis of seven countries study for a European coronary risk chart. Heart. 84, 238-244 (2000)
    • (2000) Heart. , vol.84 , pp. 238-244
    • Menotti, A.1    Lanti, M.2    Puddu, P.E.3
  • 29
    • 0033191062 scopus 로고    scopus 로고
    • Reduction in incidence of diabetes, hypertension and lip disturbances after intentional weight loss induced by bariatric surgery: The SOS intervention study
    • Sjöström, C.D., Lissner, Ö., Wedel, H., Sjöström, L.: Reduction in incidence of diabetes, hypertension and lip disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obes. Res. 7, 477-484 (1999)
    • (1999) Obes. Res. , Issue.7 , pp. 477-484
    • Sjöström, C.D.1    Lissner, Ö.2    Wedel, H.3    Sjöström, L.4
  • 30
    • 1642443523 scopus 로고    scopus 로고
    • Cost-effectiveness of sibutramine in the treatment of obesity
    • Warren, E., Brennan, A., Akehurst, R.: Cost-effectiveness of sibutramine in the treatment of obesity. Med. Decis. Making. 24, 9-18 (2004)
    • (2004) Med. Decis. Making. , vol.24 , pp. 9-18
    • Warren, E.1    Brennan, A.2    Akehurst, R.3
  • 31
    • 77954888032 scopus 로고    scopus 로고
    • Economic evaluation of diabetic glycemic control: Literature review of epidemiology and treatment costs in Sweden
    • Norinder, A., et al.: Economic evaluation of diabetic glycemic control: literature review of epidemiology and treatment costs in Sweden. Internal rapport IHE (1998)
    • (1998) Internal Rapport IHE
    • Norinder, A.1
  • 32
    • 77954887227 scopus 로고    scopus 로고
    • Priser och ersättning för sydöstra sjukvårdsregionen 2005
    • Samverkansnämnden sydöstra sjukvårdsregionen
    • Samverkansnämnden sydöstra sjukvårdsregionen. Priser och ersättning för sydöstra sjukvårdsregionen 2005 (Prices and Reimbursements in the South-East Swedish Health Care Region), p 60 (2005)
    • (2005) Prices and Reimbursements in the South-East Swedish Health Care Region , pp. 60
  • 33
    • 0032798432 scopus 로고    scopus 로고
    • Cost of coronary heart disease and stroke: The case of Sweden
    • Zethraeus, N., et al.: Cost of coronary heart disease and stroke: the case of Sweden. J. Intern. Med. 246, 151-159 (1999)
    • (1999) J. Intern. Med. , vol.246 , pp. 151-159
    • Zethraeus, N.1
  • 34
    • 4043050724 scopus 로고    scopus 로고
    • Cost of stroke in Sweden: An incidence estimate
    • Ghatnekar, O., et al.: Cost of stroke in Sweden: an incidence estimate. Int. J. Technol. Assess. Health Care. 20(3), 375-380 (2004)
    • (2004) Int. J. Technol. Assess. Health Care. , vol.20 , Issue.3 , pp. 375-380
    • Ghatnekar, O.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.